Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001193125-26-257564

Options or other derivatives

  • Director acquired 9,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Jovan-Embiricos Morana Director 2026-06-03 Grant or award · Stock Option (Right to Buy) +9,000 9,000 D
Loading xslF345X06/ownership.xml…